Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas

被引:70
作者
Baykal, C
Ayhan, A
Al, A
Yüce, K
Ayhan, A
机构
[1] Hacettepe Univ, Sch Med, Dept Obstet & Gynecol, Ankara, Turkey
[2] Hacettepe Univ, Sch Med, Dept Pathol, Ankara, Turkey
关键词
c-Met/HGFR overexpression; cervix cancer; prognosis; survival; immunohistochemistry;
D O I
10.1016/S0090-8258(02)00073-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The purpose of this study is to evaluate the significance of the c-Met/hepatocyte growth factor receptor expression in invasive cervical carcinoma. Methods. Ninety-Four patients with FIGO stage 113 disease, treated primarily with surgery, were studied immunohistochemically. Of the cases, 67 were squamous carcinoma and 27 were nonsquamous (10 were adenocarcinoma, 15 were adenosquamous carcinoma, and 2 were indifferentiated carcinoma). Immunohistochemically stained c-Met slides of primary malignancies were evaluated blindly of clinical outcome and other histopathological factors. Results. Overexpression of c-Met was found in 56 of 94 specimens. Primary tumors which show recurrences were found to be c-Met overexpressors. Univariate survival analysis (Kaplan-Meier) showed that c-Met overexpression is significantly correlated with disease-free survival. Moreover the diameter of the primary tumor, deep cervical stromal invasion, presence of metastatic lymph node, number of metastatic lymph nodes and c-Met overexpression were significantly correlated with overall 5-year survival. Furthermore multivariant analysis with Cox regression showed that the presence of metastatic lymph node and immunopositivity for c-Met are significantly correlated with overall survival, while c-Met overexpression was found to be an independent variable for disease-free survival. Conclusion. These results reveal that c-Met oncogene overexpression is an important parameter for disease progression, recurrence, and survival in early-stage invasive uterine cervix carcinomas. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 51 条
[1]   Altered CD44 variant 6 expression in FIGO stage IB cervical carcinoma [J].
Ayhan, A ;
Baykal, C ;
Al, A ;
Ayhan, A .
GYNECOLOGIC ONCOLOGY, 2001, 83 (03) :569-574
[2]   Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer:: impact on progression-free survival [J].
Bachtiary, B ;
Selzer, E ;
Knocke, TH ;
Pötter, R ;
Obermair, A .
CANCER LETTERS, 2002, 179 (02) :197-203
[3]   Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins [J].
Berger, AJ ;
Baege, A ;
Guillemette, T ;
Deeds, J ;
Meyer, R ;
Disbrow, G ;
Schlegel, R ;
Schlegel, R .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (02) :603-610
[4]  
Beviglia L, 1997, INT J CANCER, V74, P301, DOI 10.1002/(SICI)1097-0215(19970620)74:3<301::AID-IJC12>3.0.CO
[5]  
2-E
[6]  
Biesterfeld S, 1999, ONCOL REP, V6, P205
[7]   IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT [J].
BOTTARO, DP ;
RUBIN, JS ;
FALETTO, DL ;
CHAN, AML ;
KMIECIK, TE ;
VANDEWOUDE, GF ;
AARONSON, SA .
SCIENCE, 1991, 251 (4995) :802-804
[8]   The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix [J].
Chang, JL ;
Tsao, YP ;
Liu, DW ;
Han, CP ;
Lee, WH ;
Chen, SL .
GYNECOLOGIC ONCOLOGY, 1999, 73 (01) :62-71
[9]   Vascular endothelial growth factor in cervical carcinoma [J].
Cheng, WF ;
Chen, CA ;
Lee, CN ;
Chen, TM ;
Hsieh, FJ ;
Hsieh, CY .
OBSTETRICS AND GYNECOLOGY, 1999, 93 (05) :761-765
[10]  
Cortesina G, 2000, INT J CANCER, V89, P286, DOI 10.1002/1097-0215(20000520)89:3<286::AID-IJC12>3.0.CO